A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Healthcare

Major players across the healthcare industry—pharmaceutical and biotechnology companies, medical device and equipment manufacturers, health insurance companies, hospitals and other providers—turn to Simpson Thacher for deep experience navigating the complexities of the industry. From structuring multibillion dollar mergers and obtaining antitrust approval to advising on disputes and investigations, our healthcare group combines industry-specific experience with unrivaled excellence in the legal disciplines that most affect healthcare companies.  
#2
Ranked #2 in 2017 in healthcare M&A in the U.S. (based on the target industry)
(Thomson Reuters)
530
Over 530 corporate representations with an aggregate value of more than $940 billion in healthcare
(Thomson Reuters)
“Simpson Thacher couples ‘an impressive level of experience, industry knowledge and business acumen’ with a ‘deep bench.’”
--The Legal 500 2016
Pharma and Biotech
  • Celltrion Healthcare’s $900 million IPO
  • Valeant in high-profile securities fraud and RICO class actions
  • Walgreens Boots Alliance’s acquisition of 1,932 Rite Aid stores for $4.157 billion
  • Merck in a high-profile litigation and patent office dispute involving its immunotherapy products, including “the President's Drug” KEYTRUDA, against Genentech over the “Cabilly” patents
  • Secured a final award of more than US$500 million on a fraud claim brought in a ICC arbitration for Daiichi Sankyo
  • ZS Pharma’s $2.7 billion sale to AstraZeneca
  • Defense of Pfizer in multiple securities litigations
  • The CFO of a pharmaceutical company in a DOJ investigation of suspected violations of the FCPA
  • Merck and Pfizer in false advertising matters
  • biotech company in an expedited “baseball-style” arbitration against a major Japanese pharmaceutical company 
  • Pfizer and Pharmacia fiduciaries in multiple ERISA stock drop cases
Show more
Website_HButtons_160x160_2016_v05_5
  • Debt offerings for Boston Scientific
  • Avantor in its acquisition of VWR Corporation, a provider of laboratory products, services and solutions, for approximately $6.4 billion
  • medical device company in connection with allegations raised relating to FDA and FCPA compliance issues
  • Japan’s Panasonic Healthcare’s carve-out acquisition of Bayer AG’s Diabetes Care business division for $1.15 billion
  • Teleflex’s multiple acquisitions and debt offerings
  • EQT’s acquisition of Clinical Innovations
  • Equity offering for Integra LifeSciences
  • Financing for Thermo Fisher in its acquisition of Patheon
  • Acelity’s sale of its LifeCell business unit to Allergan
  • Apax Partners’ joint venture with Becton Dickinson for Respiratory Solutions Business
  • Warburg Pincus in a $76.5 million series C equity funding for Outset Medical
Show more
Payors and Providers
  • CVS Health’s $40 billion debt offering, the third-largest corporate bond sale on record, to finance its announced acquisition of Aetna
  • Cigna’s $1.6 billion debt offering and related tender offers
  • Hellman & Friedman's acquisition of MultiPlan
  • HCA’s IPO (the largest U.S. IPO of 2011) and multiple debt and equity offerings
  • American Renal Holdings’ IPO
  • An insurance carrier concerning a computer data access incident that resulted in investigations by various state and federal government and regulatory entities, including the Department of Health and Human Services and the DOJ
  • Debt offerings for Humana
  • Adeptus Health’s, a Sterling Partners portfolio company, IPO and multiple equity follow-on offerings
  • A provider of medical diagnostic services in Brazil Centro de Imagem Diagnósticos S.A. – Alliar’s IPO
Show more
Healthcare Services and IT
  • iKang’s $1.5 billion proposed going private transaction (representing the special committee of the board)
  • Weight Watchers in securing a dismissal for a securities class action alleging false and misleading statements regarding its financial performance
  • Internet Brands’, a KKR portfolio company, $2.8 billion acquisition of WebMD
  • KKR’s $1.4 billion acquisition of PharMerica, a provider of pharmacy services
  • Patient experience company Press Ganey’s IPO and multiple acquisitions as well as EQT Partners in its acquisition of the company
  • Contract research organization Quintiles’ merger with IMS Health (representing the independent directors) and Quintiles’ IPO (as special IPO counsel)
  • Blackstone’s $1.5 billion sale of life science and medical real estate assets of Wexford Science & Technology and $1.125 billion acquisition of a portfolio of senior living properties of HCP, Inc.
Show more

HC_Infograph_v07_01

HC_Infograph_v07_02
HC_Infograph_v07_03  HC_Infograph_v07_04
 HC_Infograph_v07_05 HC_Infograph_v07_06
 HC_Infograph_v09_07
 HC_Infograph_v07_08  HC_Infograph_v07_09  HC_Infograph_v07_10

News & Events

    Publications

      Contact

      Spotlight on
      Simpson Thacher Hosts 2018 Healthcare Perspectives Event
      Spotlight on
      Transferring Patents to Sovereign Entities to Avoid Inter Partes Review
      Spotlight on
      Simpson Thacher Hosts Life Sciences & Pharmaceuticals Symposium